ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 1064 • ACR Convergence 2025

    Characterization of Juvenile Idiopathic Arthritis in Indigenous North American Children enrolled in a North American registry

    Hayley M Lynch1, Jordan E. Roberts1 and James N. Jarvis2, 1Seattle Children's Hospital/UW, Seattle, WA, 2University of Washington Center for Indigenous Health, Seattle, WA

    Background/Purpose: Several studies detail a higher prevalence and severity of juvenile idiopathic arthritis (JIA) in Indigenous North American (INA) children compared to the general population.…
  • Abstract Number: 0414 • ACR Convergence 2025

    Predicting JIA-Associated Uveitis Using Tear Fluid Biomarkers: A Prospective Multicenter Study

    Mariia Pavlenko1, Mekibib Altaye2, Hermine Brunner3, Margaret Chang4, Ashley Cooper5, Stefanie Davidson6, Alexandra Duell3, Bharti Gangwani4, Aimee Hersh7, Gary Holland8, Carl Langefeld9, Melissa Lerman10, Mindy Lo4, Virginia Miraldi Utz3, Sampath Prahalad11, Grant Schulert3, Megan Quinlan-Waters12, Erin Stahl5, Edmund Tsui8 and Sheila Angeles-Han13, 1Cincinnati Children`s Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital, Cincinnati, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Boston Children's Hospital, Boston, MA, 5Children's Mercy Kansas City, Kansas City, MO, 6Department of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, Philadelphia, PA, 7University of Utah, Salt Lake City, UT, 8UCLA Jules Stein Eye Institute and the Department of Ophthalmology, UCLA David Geffen School of Medicine, Los Angeles, 9Wake Forest University School of Medicine, Winston Salem, NC, 10Division of Rheumatology, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, Philadelphia, PA, 11Emory + Children's Pediatric Institute, Atlanta, GA, 12Cincinnati Children's Hospital Medical Center, CCHMC, 13Cincinnati Children's Hospital, Cincinnati, OH

    Background/Purpose: Uveitis is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA) and can lead to vision loss if not detected early. Current clinical…
  • Abstract Number: 0374 • ACR Convergence 2025

    Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic

    Merav Heshin Bekenstein1, Rebecca Hetrick2, Vidya Sivaraman3, Beth Rutstein4, Albert Chow5, Peter Chiraseveenuprapund6, Vincent Del Gaizo7, Melanie Kohlheim8, guy Brock9, Sapuni Chandrasena9, Chloé Janse van Rensburg10 and Marina Gad El Sayed11, 1Tel Aviv Medical Center Israel, Binyamina, Tel Aviv, Israel, 2Indiana University School of Medicine, Indianapolis, IN, 3Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 4The Children's Hospital of Philadelphia, Wynnewood, PA, 5Loma Linda University, Loma Linda, CA, 6University of Utah, Salt Lake City, UT, 7Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ, 8CARRA, Granville, OH, 9The Ohio State University Wexner Medical Center, Columbus, OH, 10Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada, 11University of California, Riverside School of Medicine, Riverside, CA

    Background/Purpose: Vaccine-preventable diseases pose greater risk to children with rheumatic diseases treated with immunosuppressive therapies and to those with underlying immune dysregulation. Despite the importance…
  • Abstract Number: 2194 • ACR Convergence 2025

    Utilizing Case-Based Learning to Teach the Teacher and Improve Health Insurance Literacy

    Tyler Reese, Vanderbilt University Medical Center, Madison, TN

    Background/Purpose: It is expected that pediatric rheumatology providers prepare adolescent and young adult (AYA) patients to successfully navigate the transition from a pediatric to an…
  • Abstract Number: 2145 • ACR Convergence 2025

    EOS® Imaging System Is a Novel, Rapid, Safe, and Effective Technique To Detect And Assess Calcinosis In JDM

    Jessica Perfetto1, Ciara Maguire2, Carli Needle3, Shailee Lala4, Vikash Oza2 and Philip Kahn5, 1Pediatric Rheumatology, Hassenfeld Children's Hospital at NYU Langone, New York, 2Pediatric Dermatology, Ronald O Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, 3NYU Grossman School of Medicine, New York, 4Department of Radiology, NYU Grossman School of Medicine, New York, 5Pediatric Rheumatology, Hassenfeld Children’s Hospital at NYU Langone, New York

    Background/Purpose: Calcinosis, reported in up to 47% of children with juvenile dermatomyositis (JDM), can cause significant morbidity, including ulceration, infection, and contractures. Given associations of…
  • Abstract Number: 1847 • ACR Convergence 2025

    Spatial transcriptomics reveals a complex microanatomic patterning of complement mediated inflammation and fibrosis in Class III pediatric lupus nephritis associated with local histologic injury

    Sarah McCuaig1, Julia Rood1, Em Elliott1, Portia Kreiger1 and Edward Behrens2, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2CHOP, West Chester, PA

    Background/Purpose: Lupus nephritis (LN) occurs in over 50% of patients with pediatric systemic lupus erythematosus (pSLE) and results in significant morbidity due to suboptimal kidney…
  • Abstract Number: 1742 • ACR Convergence 2025

    S100B in Childhood-onset Systemic Lupus Erythematosus: Associations with Disease Features, Interferon Levels, and Cognitive Functioning

    Ganesh Ramanathan1, Justine Ledochowski2, Oscar Mwizerwa3, Tala El Tal4, Lawrence Ng5, Asha Jeyanathan6, Adrienne Davis6, Ann Yeh6, Linda Hiraki2, Deborah Levy2, Zahi Touma7, Joan Wither8, Busisiwe Zapparoli9, Ashley Danguecan10 and Andrea Knight10, 1The Hospital for Sick Children, Brampton, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada, 4Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada, 5The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 6The Hospital for Sick Children, Toronto, Canada, 7University of Toronto, Toronto, ON, Canada, 8University Health Network, Toronto, ON, Canada, 9The Hospital for Sick Children, Etobicoke, ON, Canada, 10Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment is common in childhood-onset systemic lupus erythematosus (cSLE), particularly in domains like executive function and attention. However, attributing cognitive difficulties to brain…
  • Abstract Number: 1302 • ACR Convergence 2025

    Dose Adjustment was Necessary in Patients with Cryopyrin-Associated Periodic Syndrome Switching from Anakinra to Canakinumab

    Soyoung Lee and Hyun Kyung Lee, Chung-Ang University Hospital, Seoul, Republic of Korea

    Background/Purpose: Cryopyrin-associated periodic syndrome (CAPS) is a spectrum of rare autoinflammatory disorders caused by mutations in the NLRP3 gene, leading to excessive interleukin-1β (IL-1 β)…
  • Abstract Number: 1284 • ACR Convergence 2025

    Clinical implications of Antiphospholipid Antibodies and Secondary Antiphospholipid Syndrome in Juvenile-onset Systemic Lupus Erythematosus

    Daniel Clemente1, Alina-Lucica Boteanu2, Clara Udaondo3, Joan Calzada4, Juan Carlos Nieto5, Eugenia Enriquez6, Inmaculada Calvo7, Lourdes Villalobos8, Belen Sevilla9, Sara Murias10, Berta Magallares11, Ana Capilla12, Jaime Arroyo13, Beatriz Bravo14, Gisela Diez-Cordoves15, Marisol Camacho16, Genaro grana17, Juan Jose Bethencourt18, Pablo Mesa19, Natalia Palmou20, Mireia Lopez Corbeto21, Judith Sanchez22, Maria Isabel Gonzalez23, Clara Moriano24, Diego Dios17, Lorena Exposito25, Alicia Garcia26, Laura Martin27, David Fernandez28, Laura Trujillo14, Anahy Maria Brandy29, CARLOS GUILLEN-ASTETE30 and lydia Abasolo Alcazar31, 1Hospital Infantil Universitario NIño Jesús, Madrid, Madrid, Spain, 2H.U. Ramón y Cajal, Madrid, Spain, 3La Paz University Hospital, Madrid, Spain, 4University Hospital Sant Joan de Deu, Barcelona, Spain, 5Hospital General Universitario Gregorio Marañón, Madrid, Spain, 6Clínica Universidad de Navarra, Madrid, Spain, 7Hospital La Fe, Valencia, Comunidad Valenciana, Spain, 8Ramon y Cajal Hospital, MADRID, Spain, 9Division of Pediatrics, Hospital Universitario San Cecilio, Granada, Spain, 10H.U Central de Asturias, Oviedo, Spain, 11Hospital de Sant Pau, Bareclona, 12H.U de La Merced, Sevilla, Spain, 13HOSPITAL UNIVERSITARIO LA PAZ, MADRID, 14H.U Virgen de Las Nieves, Granada, Spain, 15H. R. U. Malaga, Malaga, Spain, 16H.U. Virgen del Rocío, Sevilla, Spain, 17H.U de A Coruña, A Coruña, Spain, 18H.U. Canarias, Canarias, Spain, 19H.U Virgen de la Arrixaca, Murcia, Spain, 20H.U. marques de Valdecilla, Santander, Spain, 21H.U Vall d´Hebron, Barcelona, Spain, 22Pediatric Rheumatology Department, Taulí Hospital Universitari-Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Sabadell (Spain)., Sabadell, Spain, 23H.U. La Fé, Valencia, Spain, 24Hospital León, LEON, Castilla y Leon, Spain, 25H.U Canarias, Canarias, Spain, 26Rheumatologist, La Laguna, Spain, 27H.R.U Malaga, Malaga, Spain, 28Complejo Hospitalario Universitario de Vigo, Vigo, Galicia, Spain, 29Hospital Germans Trias i Pujol, Badalona, Spain, 30H.U Ramón y Cajal, Madrid, Spain, 31IdISSC. HCSC, Madrid, Madrid, Spain

    Background/Purpose: Antiphospholipid antibodies (aPL) have been associated with organ damage and certain features in juvenile-onset systemic lupus erythematosus (jSLE) patients. We aimed to assess the…
  • Abstract Number: 1059 • ACR Convergence 2025

    Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children

    Chelsea Reynolds1, Natasha Ruth2, Paul Nietert1, Mileka Gilbert1, Emily Vara1 and Joyce Chang3, 1Medical University of South Carolina, Charleston, SC, 2Medical University South Carolina, Charleston, SC, 3Boston Children's Hospital, Boston, MA

    Background/Purpose: Recent research suggests that multidimensional area-level indicators, including the Social Vulnerability Index (SVI), Area Deprivation Index (ADI) and Childhood Opportunity Index (COI), associate with…
  • Abstract Number: 0413 • ACR Convergence 2025

    Improving Access to Timely Joint Injections for Pediatric Rheumatology Patients – A Quality Improvement Initiative

    Kendra Lauer1, Vidya Sivaraman2, Melissa Argraves3, Ysabella Esteban4, Laura Pratt5, Alysha Taxter6, Shoghik Akoghlanian3, Kelly Wise7, Kathryn Anliker3, Jonnie Hughes3, James Booker3, Ashlee Leone3 and Edward Oberle3, 1Nationwide Children's Hospital, Dublin, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nationwide Children's Hospital, Columbus, OH, 4Nationwide Children's Hospital, Plain City, OH, 5Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, OH, 6Nationwide Children's, Columbus, OH, 7Nationwide Children's Hospital, Hilliard, OH

    Background/Purpose: Timely treatment for juvenile idiopathic arthritis (JIA) is essential for disease remission and decreasing risk of long-term morbidity. Intra-articular corticosteroid joint injections can treat…
  • Abstract Number: 0361 • ACR Convergence 2025

    Transition in Focus: Health Care Utilization and Disease Status in Youth with Connective Tissue Diseases— A Single-Center Experience in British Columbia, Canada

    Mercedes Chan1, Lori Tucker1, Jude AlMasoud1, Jaime Guzman2, Andrea Human1, David Cabral3, Angela How4, Wendy Wong5 and Jennifer Corpuz6, 1BC Children's Hospital, Vancouver, BC, Canada, 2University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada, 3BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 4UBC, Vancouver, BC, Canada, 5University of British Columbia, Surrey, BC, Canada, 6UBC, New Westminster, BC, Canada

    Background/Purpose: Graduating from child and family-oriented to adult-oriented health care is a vulnerable time when youth with chronic disease drop out of, or disengage from,…
  • Abstract Number: 2188 • ACR Convergence 2025

    Enhancing Pediatric Rheumatology Education Through Case-Based Learning: Impact on Knowledge, Confidence, and Elective Interest

    Nayimisha Balmuri, Hopkins, Baltimore

    Background/Purpose: Pediatric rheumatic diseases are rare and frequently under-recognized by trainees, leading to delayed diagnosis and referral. To address this gap, we developed a case-based…
  • Abstract Number: 2144 • ACR Convergence 2025

    The Association Between Age at Diagnosis and Health-Related Quality of Life in ANCA-Associated Vasculitis

    Jessica Bloom1, Kaci Pickett-Nairne2, Lori Silveira1, Cristina Burroughs3, Katrina Bargender4, Amy Bolton4, Christine Yeung4, Jennifer Gordon5, Peter Merkel6 and Karen James7, 1University of Colorado, Aurora, CO, 2University of Colorado, Denver, 3University of South Florida, Tampa, FL, 4Vasculitis Patient-Powered Research Network, Philadelphia, PA, 5Vasculitis Foundation, Kansas City, MO, 6University of Pennsylvania, Philadelphia, PA, 7University of Utah, Salt Lake City, UT

    Background/Purpose: ANCA-associated vasculitis (AAV) is a chronic autoimmune condition that significantly impacts patients’ quality of life. It is unknown whether this impact varies based on…
  • Abstract Number: 1827 • ACR Convergence 2025

    Transcriptomics and Machine Learning Unraveling the Molecular Drivers of PFAPA Flares

    Sivia Lapidus1, Tresa Ambooken2, Ellen Hakim3, Tara Lozy4, Elahe Golalipour3, Sohail Adonimohammed5, Jennifer Weiss6, Suzanne Li6, Amanda Nowakowski7, Aryeh Lejtman8, Aaron Sebbag3, Ariel Aptekmann9 and Jigar Desai9, 1Joseph M. Sanzari Children's Hospital, Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Montclair, NJ, 2Food and Drug Administration, Floral Park, NY, 3Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 4Joseph M. Sanzari Children's Hospital, Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Nutley, 5Hackensack Meridian School of Medicine, Nutley, NJ, 6Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ, 7Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Hackensack, NJ, 8Joseph M. Sanzari Children's Hospital and Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 9Center for Discovery and Innovation and Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, NJ

    Background/Purpose: Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) is the most common periodic fever presenting with frequent episodes of pain and impaired function. While…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 62
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology